Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Nel ASA Secures EU Backing for Next-Generation Hydrogen Technology

Dieter Jaworski by Dieter Jaworski
December 13, 2025
in Analysis, European Markets, Hydrogen, Renewable Energy, Turnaround
0
Nel ASA Stock
0
SHARES
32
VIEWS
Share on FacebookShare on Twitter

Norwegian hydrogen specialist Nel ASA has reached a pivotal strategic milestone. After seven years in development, the company’s board has given the final investment decision to construct up to one gigawatt of production capacity for its new electrolyzer platform. The move, announced Friday and supported by substantial European Union funding, aims to drastically improve the efficiency and economics of hydrogen production. The critical question for investors is whether this technological leap can provide a lasting foundation for the company’s recently volatile share price.

Financial Momentum and Market Reaction

The market’s initial response to the news was positive, with Nel’s shares advancing over 4% to 2.38 NOK. Central to the announcement is the commercialization of the firm’s “Next Generation Pressurized Alkaline” (NGP) systems. A key enabler for the project is financial support from the European Union’s Innovation Fund, which has committed grants covering up to 60% of relevant capital and operational expenditures, amounting to as much as 135 million euros. This commitment has triggered an immediate first disbursement of over 10 million euros.

CEO Håkon Volldal emphasized that the NGP technology is designed to reduce hydrogen costs to a level where business models can achieve profitability without relying heavily on subsidies.

Operational Challenges Amid Strategic Progress

This strategic shift comes against a backdrop of mixed operational results. Nel’s third-quarter report showed a 17% year-over-year revenue decline to 303 million Norwegian kroner. However, the company managed to significantly narrow its EBITDA loss, which improved from 90 million NOK to 37 million NOK.

Despite the recent quarterly revenue weakness, new business activity has been robust. In November alone, Nel secured an order worth more than $50 million for two 20-megawatt electrolyzer plants in Norway, marking the second-largest firm order in its history. The company’s order backlog remained solid at 984 million NOK as of the end of September.

Should investors sell immediately? Or is it worth buying Nel ASA?

Technological Advancements and Potential Write-Downs

The new technology represents a radical simplification in system design. It utilizes a modular, skid-based approach where fully assembled and pre-tested containerized units are delivered, eliminating complex on-site construction for customers and allowing for outdoor installation.

This progress, however, carries a potential financial implication for the balance sheet. Because the new pressurized technology is expected to be significantly more cost-effective, management is reviewing the book value of its existing, currently idled production lines for atmospheric alkaline electrolyzers. Investors may need to prepare for potential asset impairments as these older lines risk becoming obsolete.

Analyst Caution and the Road Ahead

The commercial launch for the new technology platform is scheduled for the first half of 2026, with scaling operations expected to follow in 2027. While the recent developments are positive, analyst sentiment remains cautious. The prevailing market consensus recommendation continues to be predominantly “Underweight,” although some institutions, including Citi, have modestly raised their price targets—Citi’s now stands at 2.70 NOK.

Further clarity on the financial trajectory will likely come with Nel’s fourth-quarter results, scheduled for release in late February 2026. Until then, the investment thesis for the stock hinges largely on the new platform’s ability to deliver its promised substantial reductions in the cost of hydrogen.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from February 7 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Independent Bank Stock
Analysis

Independent Bank Shares Approach Peak Amid Insider Selling

February 7, 2026
Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Allscripts Healthcare Stock
Analysis

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Next Post
XRP Stock

XRP's Pivotal Battle at the $2 Threshold

Boeing Stock

Boeing's Order Surge Faces Regulatory Hurdles

Adobe Stock

Adobe's AI Ambitions Come at a Cost to Profitability

Recommended

NTSB Investigative Hearing Raises Concerns About Boeing 737 Max 9 Safety Practices

2 years ago
Immunovant Inc Stock

Immunovant’s Critical Juncture: All Eyes on September Catalyst

6 months ago
Plug Power Stock

Plug Power’s Contradiction: Operational Gains Versus Market Pessimism

6 months ago
Grayscale Bitcoin Stock

Bitcoin ETFs Face Mounting Pressure as Prices Plunge Below Key Threshold

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

Yirendai Charts a New Course with Tech-Driven Strategy

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

Trending

Independent Bank Stock
Analysis

Independent Bank Shares Approach Peak Amid Insider Selling

by Rodolfo Hanigan
February 7, 2026
0

The stock of Independent Bank Corp. presents a notable market contradiction. Trading near its 52-week peak, the...

Communications Stock

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Hbt Financial Stock

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Allscripts Healthcare Stock

Navigating a Pivotal Year: Veradigm’s Dual-Path Strategy for Stability and Growth

February 7, 2026
Avanos Medical Stock

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Independent Bank Shares Approach Peak Amid Insider Selling
  • The Race to Rewire: Fiber Optics Reshape the Telecom Landscape
  • HBT Financial Stock Surges as Strategic Acquisition Nears Completion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com